Sequential Plasmodium chabaudi and Plasmodium berghei infections provide a novel model of severe malarial anemia

Infection and Immunity

Volumn 80, Issue 9, 2012, Pages 2997-3007

  Harris, Juliana V ^a   Bohr, Tiffany M ^b   Stracener, Catherine ^a   Landmesser, Mary E ^b   Torres, Vladimir ^b   Mbugua, Amos ^b   Moratz, Chantal ^a   Stoute, José A ^a,b  

^a Uniformed Services University of the Health Sciences   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; CHLOROQUINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL LABELING; CONTROLLED STUDY; ERYTHROCYTE; ERYTHROPHAGOCYTOSIS; EX VIVO STUDY; FROZEN SECTION; IMMUNOFLUORESCENCE MICROSCOPY; IN VIVO STUDY; MOUSE; NONHUMAN; PLASMODIUM BERGHEI; PLASMODIUM BERGHEI INFECTION; PLASMODIUM CHABAUDI; PLASMODIUM CHABAUDI INFECTION; PRIORITY JOURNAL; RETICULOCYTOSIS; SEVERE MALARIAL ANEMIA; TISSUE SECTION;

ANEMIA; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; LIVER; MALARIA; MICE; MICE, INBRED C57BL; PARASITEMIA; PHAGOCYTOSIS; PLASMODIUM BERGHEI; PLASMODIUM CHABAUDI; TIME FACTORS;

EID: 84867593789     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.06185-11     Document Type: Article

References (48)

1. Abdalla SH, Weatherall DJ, Wickramasinghe SN, Hughes M. 1980. The anaemia of P. falciparum malaria. Br. J. Haematol. 46:171-183.
2. Akanmori BD, et al. 2000. Distinct patterns of cytokine regulation in discrete clinical forms of Plasmodium falciparum malaria. Eur. Cytokine Netw. 11:113-118.
3. Boutlis CS, et al. 2003. Plasma interleukin-12 in malaria-tolerant Papua New Guineans: inverse correlation with Plasmodium falciparum parasitemia and peripheral blood mononuclear cell nitric oxide synthase activity. Infect. Immun. 71:6354-6357.
4. Camacho LH, et al. 1998. The course of anaemia after the treatment of acute, falciparum malaria. Ann. Trop. Med. Parasitol. 92:525-537.
5. Chang KH, Tam M, Stevenson MM. 2004. Modulation of the course and outcome of blood-stage malaria by erythropoietin-induced reticulocytosis. J. Infect. Dis. 189:735-743.
6. D'Andrea A, et al. 1993. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178:1041- 1048.
7. de Kossodo S, Grau GE. 1993. Profiles of cytokine production in relation with susceptibility to cerebral malaria. J. Immunol. 151:4811- 4820.
8. de Waal MR, Abrams J, Bennett B, Figdor CG, de Vries JE. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209-1220.
9. Dodoo D, et al. 2002. Absolute levels and ratios of proinflammatory and anti-inflammatory cytokine production in vitro predict clinical immunity to Plasmodium falciparum malaria. J. Infect. Dis. 185:971-979.
10. Egan AF, Fabucci ME, Saul A, Kaslow DC, Miller LH. 2002. Aotus New World monkeys: model for studying malaria-induced anemia. Blood 99: 3863-3866.
11. Evans KJ, Hansen DS, van Roolijen N, Buckingham LA, Schofield L. 2006. Severe malarial anemia of low parasite burden in rodent models results from accelerated clearance of uninfected erythrocytes. Blood 107: 1192-1199.
12. Feng C, et al. 1999. An alternate pathway for type 1 T cell differentiation. Int. Immunol. 11:1185-1194.
13. Fries LF, Siwik SA, Malbran A, Frank MM. 1987. Phagocytosis of target particles bearing C3b-IgG covalent complexes by human monocytes and polymorphonuclear leucocytes. Immunology 62:45-51.
14. Geldwerth D, et al. 1999. Detection of phosphatidylserine surface exposure on human erythrocytes using annexin V-ferrofluid. Biochem. Biophys. Res. Commun. 258:199 -203.
15. Giha HA, Elghazali G, Elgadir TM, Elbasit IE, Elbashir MI. 2009. Severe malaria in an unstable setting: clinical and laboratory correlates of cerebral malaria and severe malarial anemia and a paradigm for a simplified severity scoring. Eur. J. Clin. Microbiol. Infect. Dis. 28:661- 665.
16. Gomez ND, et al. 2011. Deletion of a malaria invasion gene reduces death and anemia, in model hosts. PLoS One 6:e25477. doi:10.1371/journal.pone.0025477.
17. Greenwood BM. 1997. The epidemiology of malaria. Ann. Trop. Med. Parasitol. 91:763-769.
18. Helegbe GK, et al. 2009. Rate of red blood cell destruction varies in different strains of mice infected with Plasmodium berghei-ANKA after chronic exposure. Malar. J. 8:91.
19. Ho M, et al. 1998. Endogenous interleukin-10 modulates proinflammatory response in Plasmodium falciparum malaria. J. Infect. Dis. 178:520-525.
20. Jakeman GN, Saul A, Hogarth WL, Collins WE. 1999. Anaemia of acute malaria infections in non-immune patients primarily results from destruction of uninfected erythrocytes. Parasitology 119(Pt 2):127-133.
21. Jarra W. 1983. Protective immunity to malaria and anti-erythrocyte autoimmunity. Ciba Found. Symp. 94:137-158.
22. Jarra W, Hills LA, March JC, Brown KN. 1986. Protective immunity to malaria. Studies with cloned lines of Plasmodium chabaudi chabaudi and P. berghei in CBA/Ca mice. II. The effectiveness and inter- or intra-species specificity of the passive transfer of immunity with serum. Parasite Immunol. 8:239 -254.
23. Jones TR, et al. 2002. Anemia in parasite- and recombinant proteinimmunized Aotus monkeys infected with Plasmodium falciparum. Am. J. Trop. Med. Hyg. 66:672- 679.
24. Kuypers FA, de Jong K. 2004. The role of phosphatidylserine in recognition and removal of erythrocytes. Cell. Mol. Biol. (Noisy-le-grand) 50: 147-158.
25. Layez C, et al. 2005. Plasmodium falciparum rhoptry protein RSP2 triggers destruction of the erythroid lineage. Blood 106:3632-3638.
26. Lee SH, et al. 1989. Antibody-dependent red cell removal during P. falciparum malaria: the clearance of red cells sensitized with an IgG anti-D. Br. J. Haematol. 73:396-402.
27. Looareesuwan S, et al. 1987. Dynamic alteration in splenic function during acute falciparum malaria. N. Engl. J. Med. 317:675- 679.
28. Looareesuwan S, et al. 1987. Reduced erythrocyte survival following clearance of malarial parasitaemia in Thai patients. Br. J. Haematol. 67: 473-478.
29. McNally J, O'Donovan SM, Dalton JP. 1992. Plasmodium berghei and Plasmodium chabaudi chabaudi: development of simple in vitro erythrocyte invasion assays. Parasitology 105(Pt 3):355-362.
30. Mohan K, Moulin P, Stevenson MM. 1997. Natural killer cell cytokine production, not cytotoxicity, contributes to resistance against blood-stage Plasmodium chabaudi AS infection. J. Immunol. 159:4990-4998.
31. Mohan K, Sam H, Stevenson MM. 1999. Therapy with a combination of low doses of interleukin 12 and chloroquine completely cures blood-stage malaria, prevents severe anemia, and induces immunity to reinfection. Infect. Immun. 67:513-519.
32. Mohan K, Stevenson MM. 1998. Dyserythropoiesis and severe anaemia associated with malaria correlate with deficient interleukin-12 production. Br. J. Haematol. 103:942-949.
33. Mohan K, Stevenson MM. 1998. Interleukin-12 corrects severe anemia during blood-stage Plasmodium chabaudi AS in susceptible A/J. mice. Exp. Hematol. 26:45-52.
34. Mota MM, Brown KN, Holder AA, Jarra W. 1998. Acute Plasmodium chabaudi chabaudi malaria infection induces antibodies which bind to the surfaces of parasitized erythrocytes and promote their phagocytosis by macrophages in vitro. Infect. Immun. 66:4080-4086.
35. MR4/ATCC.2008. Methods in malaria research.MR4/ATCC,Manassas, VA.
36. Owuor BO, et al. 2008. Reduced immune complex binding capacity and increased complement susceptibility of red cells from children with severe malaria-associated anemia. Mol. Med. 14:89 -97.
37. Price RN, et al. 2001. Factors contributing to anemia after uncomplicated falciparum malaria. Am. J. Trop. Med. Hyg. 65:614-622.
38. Salmon MG, De Souza JB, Butcher GA, Playfair JH. 1997. Premature removal of uninfected erythrocytes during malarial infection of normal and immunodeficient mice. Clin. Exp. Immunol. 108:471-476.
39. Sanni LA, Fonseca LF, Langhorne J. 2002. Mouse models for erythrocytic-stage malaria. Methods Mol. Med. 72:57-76.
40. Sedegah M, Finkelman F, Hoffman SL. 1994. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Proc. Natl. Acad. Sci. U. S. A. 91:10700 -10702.
41. Snow RW, et al. 1994. Severe childhood malaria in two areas of markedly different falciparum transmission in east Africa. Acta Trop. 57:289-300.
42. Srichaikul T, Panikbutr N, Jeumtrakul P. 1967. Bone-marrow changes in human malaria. Ann. Trop. Med. Parasitol. 61:40-51.
43. Stevenson MM, Riley EM. 2004. Innate immunity to malaria. Nat. Rev. Immunol. 4:169-180.
44. Stevenson MM, Tam MF, Wolf SF, Sher A. 1995. IL-12-induced protection against blood-stage Plasmodium chabaudi AS requires IFNgamma and TNF-alpha and occurs via a nitric oxide-dependent mechanism. J. Immunol. 155:2545-2556.
45. Su Z, Stevenson MM. 2002. IL-12 is required for antibody-mediated protective immunity against blood-stage Plasmodium chabaudi AS malaria infection in mice. J. Immunol. 168:1348 -1355.
46. Urban BC, et al. 2005. Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization. Infect. Immun. 73:1986-1994.
47. Waitumbi JN, Opollo MO, Muga RO, Misore AO, Stoute JA. 2000. Red cell surface changes and erythrophagocytosis in children with severe Plasmodium falciparum anemia. Blood 95:1481-1486.
48. Wu JJ, et al. 2010. Natural regulatory T cells mediate the development of cerebral malaria by modifying the proinflammatory response. Parasitol. Int. 59:232-241.